(0.00%) 5 213.50 points
(-0.02%) 39 020 points
(0.01%) 18 202 points
(-1.22%) $77.42
(0.32%) $2.21
(-0.48%) $2 313.00
(-0.99%) $27.27
(-0.80%) $980.50
(0.19%) $0.931
(0.42%) $10.95
(0.32%) $0.802
(0.17%) $91.60
2 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China...
Stats | |
---|---|
Today's Volume | 1.00 |
Average Volume | 1.00 |
Market Cap | 5.73B |
EPS | $0 ( 2023-03-27 ) |
Next earnings date | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 34.76 |
ATR14 | $0 (0.00%) |
DiaSorin S.p.A. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
DiaSorin S.p.A. Financials
Annual | 2023 |
Revenue: | $1.27B |
Gross Profit: | $738.49M (58.27 %) |
EPS: | $3.16 |
FY | 2023 |
Revenue: | $1.27B |
Gross Profit: | $738.49M (58.27 %) |
EPS: | $3.16 |
FY | 2022 |
Revenue: | $1.46B |
Gross Profit: | $884.57M (60.72 %) |
EPS: | $4.46 |
Financial Reports:
No articles found.
DiaSorin S.p.A.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators